CREASTIM REACTIV
Anti-hair loss lotion
CREASTIM Lotion is a hair care product indicated in the treatment of reactive hair loss following pregnancy, major stress, fatigue or the change of season. Thanks to a combination of targeted active ingredients, it stimulates hair growth while helping to slow down hair loss. CREASTIM Lotion can also be recommended after the end of cancer treatments to stimulate and accelerate hair growth.
-
For whom?AdultsPost partumOncology
-
Price
-
TextureNon-sticky, non-greasy.
Patient relations
-
Application tips
4 doses of 0.6 ml to the entire dry or wet scalp, 3 times a week for 2 months.
Massage the product into the skin with your fingertips.
Do not rinse.
Can be used by pregnant women (from the 2nd trimester onwards) and nursing mothers. -
In combination with the following treatments
Post cancer treatment.
Mechanisms of action
An innovative and complementary approach "IN & OUT " for a complete treatment of reactive hair loss. It is recommended to combine CREASTIM, topical lotion ("OUT "), with ANACAPS REACTIV food supplements ("IN ").
Ingredients
Active ingredients:
Creatine acts by activating the NOGGIN signal at the dermal papilla, which triggers the growth of a new hair; it accelerates the transition from the telogen phase to the next anagen phase, i.e.
Tetrapeptide is composed of the patented tripeptide sequence
Synergistic action of the two active ingredients on the production of VEGF, which will stimulate microcirculation and improve the supply of nutrients and oxygen to the bulb.
Vitamin B5 (pantothenic acid) is a precursor and a component of coenzyme A, which is essential for many cellular metabolic reactions.
Formula details:
Click on an ingredient type to highlight it in the list
Clinical results and publications
Efficacy results
Stimulated regrowth (2).
A/T growth ratio at 2 months (number of hairs in growth phase) (2).
Slowed hair loss (3).
Versus control group (4).
Tolerance results
Excellent skin tolerance (1).
Legal Notice
Efficacy study of an anti-hair loss lotion in female telogen effluvium: results from a 16 week, multicentric, controlled, randomized trial; V.Turlier, J.Loustau, M.S. Darde, L.Liegard, V.Mengeaud. EADV 2018 Poster.
(1) Skin tolerance rated by investigators.
(2) Significant increase in Anagen/Telogen ratio from month 1 vs. control (p<0.05).
(3) Hair fell out at 60'' brushing vs. control (p<0.001).
(4) Phototrichogram: superior efficacy to the 8-week control group (p<0.05).
Illustrative photographs
S1
S16
Discover the range
Contact us
Would you like to meet a sales representative?
Our medical sales representatives come to your workplace to answer all your questions about our brands and products.
The product concerned may not be available in your country. Please contact your medical sales representative for further information.
Have you noticed any side effects?
The safety and well-being of your patients is our priority. If you notice an unlisted adverse reaction to one of our products, please contact us without delay. We look forward to hearing from you!
Our commitments
Made in France
Product manufactured in our factories in France.
Conscious Care
Pierre Fabre Laboratories brands, including Ducray Dermatological Laboratories, have joined forces and collectively created Conscious Care: a dermo-cosmetic of the future that acts conscientiously towards its entire ecosystem.
Supporting associations
Ducray Dermatological Laboratories support 14 patient associations around the world, with the objective of sharing information on pathologies to improve their management.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.